These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 28757476)

  • 81. Mst1/2 signalling to Yap: gatekeeper for liver size and tumour development.
    Avruch J; Zhou D; Fitamant J; Bardeesy N
    Br J Cancer; 2011 Jan; 104(1):24-32. PubMed ID: 21102585
    [TBL] [Abstract][Full Text] [Related]  

  • 82. The Hippo signaling pathway: an emerging anti-cancer drug target.
    Tao Y; Cai F; Shan L; Jiang H; Ma L; Yu Y
    Discov Med; 2017 Aug; 24(130):7-18. PubMed ID: 28950071
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Hippo Pathway in Mammalian Adaptive Immune System.
    Yamauchi T; Moroishi T
    Cells; 2019 Apr; 8(5):. PubMed ID: 31052239
    [TBL] [Abstract][Full Text] [Related]  

  • 84. The Hippo Pathway in Liver Homeostasis and Pathophysiology.
    Driskill JH; Pan D
    Annu Rev Pathol; 2021 Jan; 16():299-322. PubMed ID: 33234023
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Hippo Signaling at the Hallmarks of Cancer and Drug Resistance.
    Kumar R; Hong W
    Cells; 2024 Mar; 13(7):. PubMed ID: 38607003
    [TBL] [Abstract][Full Text] [Related]  

  • 86. The emerging role of Hippo signaling in neurodegeneration.
    Sahu MR; Mondal AC
    J Neurosci Res; 2020 May; 98(5):796-814. PubMed ID: 31705587
    [TBL] [Abstract][Full Text] [Related]  

  • 87. The Role and Regulatory Mechanism of Hippo Signaling Components in the Neuronal System.
    Cheng J; Wang S; Dong Y; Yuan Z
    Front Immunol; 2020; 11():281. PubMed ID: 32140159
    [TBL] [Abstract][Full Text] [Related]  

  • 88. miRNAs and the Hippo pathway in cancer: Exploring the therapeutic potential (Review).
    Arora T; Kausar MA; Aboelnaga SM; Anwar S; Hussain MA; Sadaf S; Kaur S; Eisa AA; Shingatgeri VMM; Najm MZ; Aloliqi AA
    Oncol Rep; 2022 Jul; 48(1):. PubMed ID: 35699111
    [TBL] [Abstract][Full Text] [Related]  

  • 89. The Hippo pathway as a drug target in gastric cancer.
    Qiao Y; Li T; Zheng S; Wang H
    Cancer Lett; 2018 Apr; 420():14-25. PubMed ID: 29408652
    [TBL] [Abstract][Full Text] [Related]  

  • 90. The Hippo pathway in endometrial cancer: a potential therapeutic target?
    Shen X; Li Q; Sun Y; Chen L; Xue F; Tian W; Wang Y
    Front Oncol; 2023; 13():1273345. PubMed ID: 37927473
    [TBL] [Abstract][Full Text] [Related]  

  • 91. RICH1 inhibits breast cancer stem cell traits through activating kinases cascade of Hippo signaling by competing with Merlin for binding to Amot-p80.
    Tian Q; Gao H; Zhou Y; Zhu L; Yang J; Wang B; Liu P; Yang J
    Cell Death Dis; 2022 Jan; 13(1):71. PubMed ID: 35064101
    [TBL] [Abstract][Full Text] [Related]  

  • 92. The role of the Hippo pathway in human disease and tumorigenesis.
    Barron DA; Kagey JD
    Clin Transl Med; 2014; 3():25. PubMed ID: 25097728
    [TBL] [Abstract][Full Text] [Related]  

  • 93. The roles of the Hippo pathway in cancer metastasis.
    Janse van Rensburg HJ; Yang X
    Cell Signal; 2016 Nov; 28(11):1761-72. PubMed ID: 27519476
    [TBL] [Abstract][Full Text] [Related]  

  • 94. The Hippo Pathway: Immunity and Cancer.
    Taha Z; Janse van Rensburg HJ; Yang X
    Cancers (Basel); 2018 Mar; 10(4):. PubMed ID: 29597279
    [TBL] [Abstract][Full Text] [Related]  

  • 95. The Role of Mst1 in Lymphocyte Homeostasis and Function.
    Cheng J; Jing Y; Kang D; Yang L; Li J; Yu Z; Peng Z; Li X; Wei Y; Gong Q; Miron RJ; Zhang Y; Liu C
    Front Immunol; 2018; 9():149. PubMed ID: 29459865
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Hippo Signaling in the Immune System.
    Zhang Y; Zhang H; Zhao B
    Trends Biochem Sci; 2018 Feb; 43(2):77-80. PubMed ID: 29249569
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Cell Junctions in Hippo Signaling.
    Karaman R; Halder G
    Cold Spring Harb Perspect Biol; 2018 May; 10(5):. PubMed ID: 28600393
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Interaction of the Hippo Pathway and Phosphatases in Tumorigenesis.
    Sarmasti Emami S; Zhang D; Yang X
    Cancers (Basel); 2020 Aug; 12(9):. PubMed ID: 32867200
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Dysregulation of the Hippo pathway signaling in aging and cancer.
    Yeung YT; Guerrero-Castilla A; Cano M; Muñoz MF; Ayala A; Argüelles S
    Pharmacol Res; 2019 May; 143():151-165. PubMed ID: 30910741
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Mutual regulation of the Hippo/Wnt/LPA/TGF‑β signaling pathways and their roles in glaucoma (Review).
    Wang X; Huai G; Wang H; Liu Y; Qi P; Shi W; Peng J; Yang H; Deng S; Wang Y
    Int J Mol Med; 2018 Mar; 41(3):1201-1212. PubMed ID: 29286147
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.